Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Covid-19 Pool
We need a Global Vaccines Taskforce, not just a British or...
Christopher Garrison
-
February 24, 2021
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
COVID-19 Technology Access Pool (C-TAP): A Promising Human Rights Approach
Medicines Law & Policy
-
June 18, 2020
Medicines Law & Policy welcomes WHO’s Solidarity Call to Action to...
Medicines Law & Policy
-
May 29, 2020
Price, profit and the Covid-19 health technology pool: The example of...
Christopher Garrison
-
May 28, 2020
Watch the webinar on the WHO Covid-19 Technology Pool
Medicines Law & Policy
-
May 15, 2020
Invitation: 14 May 2020 – The WHO Covid-19 Technology Pool: The...
Kaitlin Mara
-
May 12, 2020
The € 7.4 billion for Covid-19 product and vaccine development needs...
Ellen 't Hoen
-
May 5, 2020
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok